| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $120.7M | -1.4% | +34.4% |
| Operating Income | -$174.8M | +0.7% | -43.2% |
| Pre-tax Income | -$129.8M | +37.0% | -12.7% |
| Income Tax | $100K | +0.0% | +0.0% |
| Net Income | -$129.9M | +36.9% | -12.7% |
| EPS (Basic) | -$0.20 | +44.4% | +31.0% |
| EPS (Diluted) | -$0.20 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $595.5M | -65.5% | +18.7% |
| Current Assets | $1.69B | -3.7% | +223.5% |
| Total Assets | $1.90B | -2.0% | +191.6% |
| Current Liabilities | $93.0M | +18.0% | +7.3% |
| Total Liabilities | $245.3M | -4.7% | +33.5% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$303.6M | — | — |
| Capital Expenditures | $49.2M | — | — |
| Investing Cash Flow | -$1.10B | — | — |
| Financing Cash Flow | $1.17B | — | — |
| Free Cash Flow | -$352.8M | — | — |
| +44.4% |
| +31.0% |
| $1.65B |
| -1.6% |
| +253.7% |